Skip to main content
. 2014 Jun 8;2:418–426. doi: 10.1016/j.mgene.2014.04.012

Table 2.

Associations between MLN, MLNR, SSTR2 and SSTR5 genotypes with the risk of biliary tract cancers and stones.

Genotype
Controls
Biliary stonesa
Biliary tract cancer

n (%)
n (%)
ORd (95% CI)
Gallbladderb
Bile ductc
A.V.c
n (%) ORd (95% CI) n (%) ORd (95% CI) n (%) ORd (95% CI)
MLN 477 439 253 133 53
rs2281820
 CC 346 (77.6) 317 (73.9) 1.00 189 (74.7) 1.00 94 (70.7) 1.00 39 (75.0) 1.00
 CT 92 (20.6) 107 (24.9) 1.52 (1.06–2.18) 62 (24.5) 1.30 (0.89–1.90) 37 (27.8) 1.48 (0.94–2.33) 13 (25.0) 1.25 (0.63–2.45)
 TT 8 (1.8) 5 (1.2) 0.58 (0.18–1.82) 2 (0.8) 2 (1.5)
 CT ± TT 100 (22.4) 112 (26.1) 1.42 (1.00–2.00) 64 (25.3) 1.23 (0.85–1.79) 39 (29.3) 1.42 (0.91–2.21) 13 (25.0) 1.13 (0.57–2.20)
P trend 0.03 0.20 0.09 0.59
Rs3793079
 AA 295 (66.1) 246 (57.3) 1.00 162 (64.0) 1.00 75 (56.4) 1.00 32 (61.5) 1.00
 AT 135 (30.3) 166 (38.7) 1.64 (1.20–2.25) 80 (31.6) 1.08 (0.77–1.53) 54 (40.6) 1.58 (1.04–2.38) 18 (34.6) 1.19 (0.64–2.21)
 TT 16 (3.6) 17 (4.0) 1.15 (0.55–2.38) 11 (4.4) 1.26 (0.56–2.80) 4 (3.0) 2 (3.9)
 AT ± TT 151 (33.9) 183 (42.7) 1.58 (1.17–2.13) 91 (36.0) 1.10 (0.79–1.54) 58 (43.6) 1.49 (1.00–2.23) 20 (38.5) 1.18 (0.65–2.14)
P trend 0.002 0.62 0.03 0.58
Rs2281819
 AA 343 (76.9) 315 (73.4) 1.00 181 (71.5) 1.00 95 (71.4) 1.00 40 (76.9) 1.00
 AT 99 (22.2) 108 (25.2) 1.34 (0.95–1.90) 71 (28.1) 1.39 (0.97–2.01) 36 (27.1) 1.31 (0.83–2.05) 11 (21.2) 0.90 (0.44–1.83)
 TT 4 (0.9) 6 (1.4) 1 (0.4) 2 (1.5) 1 (1.9)
 AT ± TT 103 (23.1) 114 (26.6) 1.33 (0.95–1.87) 72 (28.5) 1.35 (0.94–1.94) 38 (28.6) 1.32 (0.85–2.06) 12 (23.1) 0.95 (0.48–1.88)
P trend 0.10 0.08 0.23 0.81



MLNR
Rs9568169
 CC 151 (33.9) 129 (30.1) 1.00 89 (35.2) 1.00 54 (40.6) 1.00 19 (36.5) 1.00
 CA 199 (44.6) 212 (49.5) 1.30 (0.93–1.81) 115 (45.4) 1.00 (0.70–1.42) 61 (45.9) 0.86 (056–1.32) 25 (48.1) 1.00 (0.53–1.90)
 AA 96 (21.5) 87 (20.3) 1.29 (0.85–1.95) 49 (19.4) 0.95 (0.61–1.48) 18 (13.5) 0.49 (0.27–0.89) 8 (15.4) 0.59 (0.25–1.41)
 CA ± AA 295 (66.1) 299 (69.9) 1.30 (0.95–1.77) 164 (64.8) 0.98 (0.71–1.37) 79 (59.4) 0.73 (0.49–1.10) 33 (63.5) 0.86 (0.47–1.57)
P trend 0.13 1.00 0.56 0.93



SSTR2
Rs7210080
 TT 230 (51.6) 215 (50.1) 1.00 117 (46.2) 1.00 75 (56.4) 1.00 28 (53.9) 1.00
 TC 176 (39.4) 183 (42.7) 1.04 (0.77–1.41) 112 (44.3) 1.25 (0.90–1.74) 47 (35.3) 0.82 (0.54–1.25) 17 (32.7) 0.78 (0.41–1.48)
 CC 40 (9.0) 31 (7.2) 0.70 (0.41–1.20) 24 (9.5) 1.12 (0.64–1.97) 11 (8.3) 0.83 (0.40–1.71) 7 (13.4) 1.50 (0.61–3.70)
 TC + CC 216 (48.4) 214 (49.9) 0.97 (0.73–1.30) 136 (53.8) 1.23 (0.89–1.68) 58 (43.6) 0.82 (0.55–1.22) 24 (46.1) 0.91 (0.51–1.62)
P trend 0.84 0.19 0.35 0.49
Rs1466113
 GG 121 (27.1) 112 (26.1) 1.00 76 (30.0) 1.00 34 (25.6) 1.00 16 (30.8) 1.00
 GC 240 (53.8) 221 (51.5) 1.08 (0.76–1.51) 120 (47.5) 0.83 (0.58–1.20) 65 (48.9) 0.96 (0.60–1.55) 18 (34.6) 0.53 (0.26–1.09)
 CC 85 (19.1) 96 (22.4) 1.31 (0.85–2.01) 57 (22.5) 1.12 (0.71–1.75) 34 (25.5) 1.46 (0.84–2.56) 18 (34.6) 1.63 (0.78–3.41)
 GC + CC 325 (72.9) 317 (73.9) 1.14 (0.82–1.57) 177 (70.0) 0.91 (0.64–1.28) 99 (74.4) 1.09 (0.70–1.71) 36 (69.2) 0.81 (0.43–1.52)
P trend 0.82 0.26 0.69 0.05
Rs2236748
 GG 304 (68.2) 315 (73.6) 1.00 185 (73.1) 1.00 92 (69.2) 1.00 42 (80.8) 1.00
 GA 126 (28.2) 108 (25.2) 0.91 (0.65–1.27) 64 (25.3) 0.83 (0.58–1.20) 38 (28.6) 1.02 (0.66–1.59) 10 (19.2) 0.58 (0.28–1.20)
 AA 16 (3.6) 5 (1.2) 4 (1.6) 3 (2.2)
 GA + AA 142 (31.8) 114 (26.4) 0.83 (0.61–1.15) 68 (26.9) 0.79 (0.55–1.12) 41 (30.8) 0.97 (0.63–1.48) 10 (19.2) 0.51 (0.25–1.06)
P trend 0.45 0.27 0.98
Rs2236750
 GG 122 (27.5) 138 (32.2) 1.00 73 (28.9) 1.00 47 (35.3) 1.00 21 (40.4) 1.00
 GA 231 (52.0) 214 (49.9) 0.78 (0.56–1.10) 124 (49.0) 0.92 (0.63–1.33) 62 (46.6) 0.67 (0.43–1.05) 21 (40.4) 0.49 (0.26–0.94)
 AA 91 (20.5) 77 (17.9) 0.70 (0.46–1.07) 56 (22.1) 1.00 (0.64–1.57) 24 (18.1) 0.68 (0.38–1.20) 10 (19.2) 0.65 (0.29–1.46)
 GA + AA 322 (72.5) 291 (67.8) 0.76 (0.55–1.05) 180 (71.1) 0.94 (0.66–1.34) 86 (64.7) 0.67 (0.44–1.02) 31 (59.6) 0.53 (0.29–0.97)
P trend 0.20 0.63 0.09 0.03



SSTR5
Rs169068
 TT 268 (60.2) 259 (61.5) 1.00 160 (63.5) 1.00 79 (59.4) 1.00 28 (53.9) 1.00
 TC 157 (35.3) 145 (34.4) 0.91 (0.67–1.24) 80 (31.7) 0.82 (0.59–1.15) 41 (30.8) 0.92 (0.60–1.42) 21 (40.4) 1.29 (0.71–2.37)
 CC 20 (4.5) 17 (4.0) 1.02 (0.49–2.13) 12 (4.8) 0.95 (0.44–2.05) 13 (9.8) 2.40 (1.13–5.13) 3 (5.8)
 TC + CC 177 (39.8) 162 (38.5) 0.92 (0.69–1.24) 92 (36.5) 0.84 (0.60–1.16) 54 (40.6) 1.08 (0.72–1.62) 24 (46.1) 1.32 (0.74–2.37)
P trend 0.57 0.26 0.84 0.39

OR, odds ratio; 95% CI, 95% confidence interval.

Test of trend for the number of copies of the variant allele (0, 1 and 2).

Did not calculate OR when N was less than 5.

a

Biliary stone (gallstone and bile duct stone) cases were compared to controls without biliary stones (n = 341).

b

Gallbadder cancer cases were compared with population controls who never had a cholecystectomy (n = 422).

c

Bile duct and ampulla of Vater cancer cases were compared with all population controls (n = 447).

d

Adjusted for age and gender.